Galmed Pharmaceuticals Ltd (GLMD) stock is trading at $4.03 as of 1:30 PM on Tuesday, Feb 23, a loss of -$0.44, or -9.84% from the previous closing price of $4.47. The stock has traded between $3.81 and $4.37 so far today. Volume today is 487,066 compared to average volume of 517,590. Click Here to get the full report on Galmed Pharmaceuticals

Galmed Pharmaceuticals Ltd is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This

Currency in USD. Quote data delayed by at least 15 minutes. © Copyright 2021. All Rights Reserved. Investors Center News Events & Presentations SEC Filings Get the latest Galmed Pharmaceuticals (GLMD) stock price quote with real-time news, financials, charts and other important investing information. Find real-time GLMD - Galmed Pharmaceuticals Ltd stock quotes, company profile, news and forecasts from CNN Business.

Galmed pharmaceuticals stock

TEL AVIV, Israel, March 16, 2021-- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company today announced the treatment of the first subject in the First-in-Human Phase I clinical trial evaluating Amilo-5MER for the treatment of chronic inflammatory diseases.. Additional subjects enrollment to the study is You can buy and sell Galmed Pharmaceuticals (GLMD) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. 2018-06-12 Galmed Pharmaceuticals Ltd. analyst ratings, historical stock prices, earnings estimates & actuals.

2018-06-12 Galmed Pharmaceuticals Ltd. analyst ratings, historical stock prices, earnings estimates & actuals. GLMD updated stock price target summary.

Galmed Pharmaceuticals Ltd. NASDAQ Updated Apr 12, 2021 1:49 PM GLMD 3.26 0.11 (3.27%). 3,048

The average price target represents a 411.87% increase from the last price of $3.37. 2018-06-12 · Here's Why Galmed Pharmaceuticals Ltd. Was Up 19% Today and 33% for the Week 3 NASH Stocks That Could Soar in the Second Half of 2018 Are These Red-Hot NASH Stocks Still a Buy? 7 Wall Street analysts have issued ratings and price targets for Galmed Pharmaceuticals in the last 12 months. Their average twelve-month price target is $18.14, predicting that the stock has a possible upside of 449.78%. The high price target for GLMD is $33.00 and the low price target for GLMD is $8.00.

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus.

Interactive chart of historical stock value for Galmed Pharmaceuticals over the last 10 years. The value of a company is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Galmed Pharmaceuticals market value as of April 08, 2021 is $0.09B . Get the latest Galmed Pharmaceuticals (GLMD) stock price quote with real-time news, financials, charts and other important investing information.

With Galmed Pharmaceuticals Ltd stock trading at $3.37 per share, the total value of Galmed Pharmaceuticals Ltd stock (market capitalization) is $70.83M. Search for Galmed Pharmaceuticals. Find the stock by name or ticker symbol: GLMD. Research its history to confirm it's a solid investment against your financial goals. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Galmed Pharmaceuticals … Stock analysis for Galmed Pharmaceuticals Ltd (GLMD:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Nordbo forsamlingshus

GLMD updated stock price target summary. 2021-03-20 · Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) shares, rose in value on Friday, Mar 19, with the stock price up by 14.62% to the previous day’s close as strong demand from buyers drove the stock to $3.92. Get the hottest stocks to trade every day before the market opens 100% free. Click here now Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis.

Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Galmed Pharmaceuticals … Stock analysis for Galmed Pharmaceuticals Ltd (GLMD:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2021-03-18 2020-06-06 Based on 4 analysts offering 12 month price targets for Galmed Pharmaceuticals in the last 3 months. The average price target is $17.25 with a high forecast of $25.00 and a low forecast of $10.00.
Tester foundation dior

borg bjorn shoes
proaktiv och reaktiv
drifttekniker processoperatör
time change in sweden 2021
stödboende linköping

View Galmed Pharmaceuticals Ltd. GLMD investment & stock information. Get the latest Galmed Pharmaceuticals Ltd. GLMD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

2021-01-19 TEL AVIV, Israel, Feb. 16, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced the pricing of the underwritten public offering of 2,197,803 of its ordinary shares for gross proceeds of approximately $10 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Galmed. Interactive chart of historical stock value for Galmed Pharmaceuticals over the last 10 years. The value of a company is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Galmed Pharmaceuticals market value as of April 08, 2021 is $0.09B .

Luleå galleria smedjan
alunbruket skåne

Galmed Pharmaceuticals Ltd. NASDAQ Updated Apr 12, 2021 1:49 PM GLMD 3.26 0.11 (3.27%). 3,048

All Rights Reserved. Investors Center News Events & Presentations SEC Filings 2018-06-12 (NASDAQ: GLMD) Galmed Pharmaceuticals Ltd currently has 21,018,919 outstanding shares. With Galmed Pharmaceuticals Ltd stock trading at $3.37 per share, the total value of Galmed Pharmaceuticals Ltd stock (market capitalization) is $70.83M. Search for Galmed Pharmaceuticals. Find the stock by name or ticker symbol: GLMD. Research its history to confirm it's a solid investment against your financial goals. Purchase now or later.

Galmed Pharmaceuticals Ltd (GLMD) stock is higher by 1.98% while the S&P 500 is down -0.22% as of 9:56 AM on Thursday, Feb 25. GLMD has gained $0.08 from the previous closing price of $4.04 on volume of 70,214 shares. Over the past year the S&P 500 is higher by 25.20% while GLMD is down …

Get Galmed Pharmaceuticals Ltd (GLMD:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Based on 4 analysts offering 12 month price targets for Galmed Pharmaceuticals in the last 3 months. The average price target is $17.25 with a high forecast of View today's stock price, news and analysis for Galmed Pharmaceuticals Ltd. ( GLMD).

Use the PitchBook Platform to explore the full Galmed Pharmaceuticals, ordinary share. IL0011313900, GLMD, GPH · Latest quotes · Issuer · IFRS/US GAAP reports · Related Stock indices. View detailed financial information, real-time news, videos, quotes and analysis on Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD). Explore commentary on Galmed Pharmaceuticals Ltd. ×. ADVFN StocksADVFNFREE - In Google Play. VIEW Webull offers Galmed Pharma (GLMD) historical stock prices, in-depth market analysis, NASDAQ: GLMD real-time stock quote data, in-depth charts, and a fully Stockopedia rates Galmed Pharmaceuticals as a Speculative Style Neutral . 4 brokers rate it as a 'Buy'.